SYSTANE® BALANCE Lubricant Eye Drops
OtherSubjects will be dosed (bilaterally) in the office during each visit. Between visits 2 and 3, patients will dose 4 times per day for the 7 day period.
NCT Number: NCT01223040
The purpose of this study is to evaluate the effect of acute and repeat dosing of Systane Balance on Video Ocular Protection Index (OPI) and Blink Patterns in a population of dry eye patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will be dosed (bilaterally) in the office during each visit. Between visits 2 and 3, patients will dose 4 times per day for the 7 day period.
Time frame: 8 days
Time frame: 9 days
Time frame: 9 days
Time frame: 9 days
Alcon Research
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04343287
Dry Eye Syndrome, Dry Eye Syndromes
Newport Beach, California, United States
View Trial DetailsNCT03066219
Dry Eye Syndrome, Dry Eye Syndromes
Lewiston, Maine, United States
View Trial DetailsNCT06375499
Dry Eye Syndrome, Dry Eye Syndromes
Prague, Czechia
View Trial DetailsNCT01013077
Dry Eye Syndrome, Dry Eye Syndromes
Fullerton, California, United States
View Trial Details